PD Dr. Ramona Schulz-Heddergott
Ramona Schulz-Heddergott is a Principal Investigator in SP9 and one of two Equity Officers of the RTG 2978.
Her research focus lies on the targeting of stress response pathways in gastrointestinal cancers and the identification of distinct pathway regulations by specific p53 mutants in colorectal and pancreatic cancer.
Dr. Schulz-Heddergott has been a lecturer and supervisor of B.Sc, M.Sc, and PhD students, as well as Clinician Scientists, since 2012. Furthermore, she has been teaching seminars for medical students of the UMG Promotionskolleg. In addition, she has been a member of various Doctoral and Thesis Advisory Committees of the UMG, the University of Göttingen Graduate Schools (GGNB) and the International Max Planck Research School (IMPRS-GS). Since 2020, she has organized Gender Equality measures within the KFO 5002.
| Year | Position |
|---|---|
| 2023 | Granted by the Heisenberg Program, DFG |
| 2021 | Habilitation, Venia Legendi for Molecular Medicine, University of Göttingen |
| Since 2018 | Group leader, Principal investigator granted by DFG; Department of Molecular Oncology, University Medical Center Göttingen |
| 2013-2018 | Research Fellow, Department of Molecular Oncology, University Medical Center Göttingen |
| 2009-2012 | Post-doctoral research, Molecular Oncology, University Medical Center Göttingen |
| 2008-2009 | Post-doctoral research, Sir William Dunn School of Pathology, University of Oxford, UK |
| 2003-2008 | Dr. rer. nat, Department of Neuroanatomy, University Medical Center Göttingen, (Supervisor: Prof. Kerstin Krieglstein) |
| 1998-2003 | Diploma studies in Biology, University of Göttingen, Germany |